Table 3. Multivariate analyses for DFS and OS.
Variables | Hazard ratio | P value |
---|---|---|
DFS | ||
CTC count (≥2) | 3.28 (1.24–8.67) | 0.017 |
CEA (>5 ng/mL) | 4.12 (2.25–7.57) | <0.001 |
Number of lung metastases (multiple) | 2.04 (1.12–3.71) | 0.037 |
History of liver metastasis (present) | 1.32 (0.69–2.53) | 0.403 |
Disease-free interval (≤24 months) | 2.45 (1.10–5.45) | 0.028 |
OS | ||
CTC count (≥2) | 2.51 (0.69–9.09) | 0.176 |
CEA (>5 ng/mL) | 5.74 (1.63–20.15) | 0.006 |
Disease-free interval (≤24 months) | 5.09 (0.61–42.45) | 0.133 |
CTC, circulating tumour cell; CEA, carcinoembryonic antigen; DFS, disease-free survival; OS, overall survival.